Trades on 1 secondary market
Ataraxis AI
Ataraxis AI is a precision-medicine company building clinical AI foundation models that make disease predictable, beginning with oncology. Founded in 2022 by Jan Witowski, MD, PhD, and Krzysztof Geras, PhD (both formerly of NYU), Ataraxis trains multi-modal AI on hundreds of millions of pathology im
Ataraxis AI is an API provider whose private shares are listed on 1 secondary market: Nasdaq Private Market.
Where It Trades
Listing data is compiled from the public marketplace pages of Forge Global, Hiive, EquityZen, Nasdaq Private Market, and Augment. A listing indicates that a venue has published a page for this company — it is not an offer, a quote, or investment advice, and APIs.io has no affiliation with any venue.